Holders over time
- VCYT
- ELV
| Quarter | VCYT | ELV |
|---|---|---|
| Q3 2020 | 4 holders, $483m | 30 holders, $15.0bn |
| Q4 2020 | 4 holders, $790m | 29 holders, $16.7bn |
| Q1 2021 | 4 holders, $891m | 25 holders, $18.6bn |
| Q2 2021 | 4 holders, $480m | 30 holders, $19.4bn |
| Q3 2021 | 4 holders, $816m | 26 holders, $18.5bn |
| Q4 2021 | 4 holders, $760m | 29 holders, $23.3bn |
| Q1 2022 | 5 holders, $376m | 31 holders, $23.9bn |
| Q2 2022 | 3 holders, $233m | 32 holders, $23.3bn |
| Q3 2022 | 2 holders, $214m | 34 holders, $22.6bn |
| Q4 2022 | 4 holders, $452m | 34 holders, $25.5bn |
| Q1 2023 | 4 holders, $430m | 39 holders, $22.5bn |
| Q2 2023 | 5 holders, $503m | 38 holders, $20.6bn |
| Q3 2023 | 5 holders, $406m | 34 holders, $19.8bn |
| Q4 2023 | 4 holders, $496m | 36 holders, $20.3bn |
| Q1 2024 | 3 holders, $388m | 35 holders, $21.3bn |
| Q2 2024 | 4 holders, $380m | 33 holders, $22.1bn |
| Q3 2024 | 5 holders, $510m | 30 holders, $20.2bn |
| Q4 2024 | 7 holders, $657m | 32 holders, $15.9bn |
| Q1 2025 | 4 holders, $388m | 28 holders, $17.1bn |
| Q2 2025 | 3 holders, $278m | 27 holders, $14.8bn |
| Q3 2025 | 3 holders, $407m | 27 holders, $12.7bn |
| Q4 2025 | 4 holders, $429m | 25 holders, $17.0bn |
| Q1 2026 | 4 holders, $278m | 26 holders, $13.6bn |
| Q2 2026 | 7 holders, $663m | 28 holders, $17.7bn |
Veracyte Inc
- Holders
- 3
- Reported value
- $407m
- Buyers
- 3
- Sellers
- 0
Breadth +3 among 95 comparable managers.
Elevance Health Inc Formerly
- Holders
- 27
- Reported value
- $12.7bn
- Buyers
- 18
- Sellers
- 9
Breadth +9 among 95 comparable managers.
Who holds both, Q3 2025
Both (1)
Only VCYT (2)
ARK Investment Management LLC, Farallon Capital Management LLC
Only ELV (26)
Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Arrowstreet Capital LP, Baillie Gifford & Co, Baupost Group LLC, Brevan Howard Capital Management LP, Bridgewater Associates LP, Capital Research Global Investors, D. E. Shaw & Co., Discovery Capital Management LLC, Dodge & Cox, First Eagle Investment Management LLC, Harris Associates LP, Invesco Ltd, Janus Henderson Group Ltd, MFS Investment Management, Moore Capital Management LP, Quantbot Technologies LP, Ruane Cunniff & Goldfarb LP, Schonfeld Strategic Advisors LLC, Squarepoint Ops LLC, T. Rowe Price Associates Inc, Tudor Investment Corp, Two Sigma Investments LP, and 1 more
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.